LRRK2 and Parkinson disease: In the NeuroX cohort, compared to controls, the majority of additional variants harboured by G2019S-positive LRRK2 cases in both cohorts were within recessive PD genes (NeuroX: 14.7% vs. 5.7%, P = 0.007, Pcorr = 0.007; Table 4).